/ SEPRDD /

Acute Heart Failure causes patients' Central Venous Pressure to rise, necessitating regular, precise administration of diuretic drugs to flush fluids and lower pressure. Traditionally, this is managed through manual titration and external pumps, which is labor-intensive and delayed.

SEPRDD changes this by operating as a completely closed-loop internal intervention device. A specialized invasive catheter containing both a pressure sensor wire and a drug delivery lumen is inserted into the subclavian or jugular vein, connecting directly to the compact, biocompatible housing of the SEPRDD device.

The device houses an ESP8266 microcontroller and an MS5837 pressure sensor that continuously log CVP. When the pressure exceeds critical thresholds, the microcontroller triggers an internal actuation motor to precisely dispense diuretic medication from an onboard reservoir directly into the vein, immediately lowering the patient's CVP without requiring physician intervention.

The SEPRDD system offers a revolutionary leap in Acute Heart Failure intervention by creating an autonomous, self-regulating mechanism for fluid and pressure management, potentially saving thousands of lives and drastically reducing hospital readmissions.

MedArc Engineering